Moleculin Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. 

CEO
Walter V. Klemp
CEOWalter V. Klemp
Employees
17
Employees17
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2015
Founded2015
Employees
17
Employees17

MBRX Key Statistics

Market cap
8.26M
Market cap8.26M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
18.30K
Average volume18.30K
High today
$8.10
High today$8.10
Low today
$7.71
Low today$7.71
Open price
$7.90
Open price$7.90
Volume
9.74K
Volume9.74K
52 Week high
$229.40
52 Week high$229.40
52 Week low
$3.23
52 Week low$3.23

Stock Snapshot

As of today, Moleculin Biotech(MBRX) shares are valued at $7.82. The company's market cap stands at 8.26M, with a P/E ratio of -0.02.

On 2026-11-15, Moleculin Biotech(MBRX) stock moved within a range of $7.71 to $8.10. With shares now at $7.82, the stock is trading +1.4% above its intraday low and -3.5% below the session's peak.

Trading activity shows a volume of 9.74K, compared to an average daily volume of 18.3K.

The stock's 52-week range extends from a low of $3.23 to a high of $229.40.

The stock's 52-week range extends from a low of $3.23 to a high of $229.40.

MBRX News

TipRanks 3d
Moleculin Biotech Announces Australian Patent for Annamycin Formulation

Moleculin Biotech ( (MBRX) ) has provided an update. On November 12, 2026, Moleculin announced that Australian Patent No. 2020303572 had been granted to the co...

People also own

Based on the portfolios of people who own MBRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.